1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 41, Issue 3, 2011, Pages 822-832

  Mayne, Christopher G ^a   Spanier, Justin A ^b   Relland, Lance M ^a   Williams, Calvin B ^a   Hayes, Colleen E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Autoimmunity; EAE MS; Knockout mice; T cells; Transcription factors

Indexed keywords

CALCITRIOL; TRANSCRIPTION FACTOR FOXP3; VITAMIN D RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HEMATOPOIETIC CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CALCITRIOL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CALCITRIOL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 79951782445     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040632     Document Type: Article

References (47)

1. Hauser, S. L. and Oksenberg, J. R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006. 52: 61-76.
2. Ascherio, A., Munger, K. L. and Simon, K. C., Vitamin D and multiple sclerosis. Lancet Neurol. 2010. 9: 599-612.
3. Acheson, E. D., Bachrach, C. A. and Wright, F. M., Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr. Scand. 1960. 35: 132-147.
4. Prosser, D. E. and Jones, G., Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004. 29: 664-673.
5. Bhalla, A. K., Amento, E. P., Clemens, T. L., Holick, M. F. and Krane, S. M., Specific high-affinity receptors for 1, 25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 1983. 57: 1308-1310.
6. Provvedini, D. M., Tsoukas, C. D., Deftos, L. J. and Manolagas, S. C., 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983. 221: 1181-1183.
7. Hayes, C. E., Cantorna, M. T. and DeLuca, H. F., Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med. 1997. 216: 21-27.
8. Hayes, C. E., Nashold, F. E., Mayne, C. G., Spanier, J. A. and Nelson, C. D., Vitamin D and multiple sclerosis. In Feldman, D., Pike, J. W. and Adams, J. S. (Eds.) Vitamin D, 3rd Edn, Elsevier, San Diego, CA 2010, in press.
9. Burton, J. M., Kimball, S., Vieth, R., Bar-Or, A., Dosch, H., Thibault, L., Kilborn, S. et al., A Phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis. Mult. Scler. 2008. 14.
10. Wingerchuk, D. M., Lesaux, J., Rice, G. P., Kremenchutzky, M. and Ebers, G. C., A pilot study of oral calcitriol (1, 25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2005. 76: 1294-1296.
11. Smolders, J., Peelen, E., Thewissen, M., Menheere, P., Cohen Tervaert, J. W., Hupperts, R. and Damoiseaux, J., The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev. 2009. 8: 621-626.
12. Torkildsen, O., Knappskog, P. M., Nyland, H. I. and Myhr, K. M., Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch. Neurol. 2008. 65: 809-811.
13. ANZgene Consortium, Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009. 41: 824-828.
14. *1501 is regulated by vitamin D. PLoS Genet. 2009. 5: e1000369.
15. Spach, K. M. and Hayes, C. E., Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 2005. 175: 4119-4126.
16. Cantorna, M. T., Hayes, C. E. and DeLuca, H. F., 1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996. 93: 7861-7864.
17. Nashold, F. E., Hoag, K. A., Goverman, J. and Hayes, C. E., Rag-1-dependent cells are necessary for 1, 25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2001. 119: 16-29.
18. Nashold, F. E., Miller, D. J. and Hayes, C. E., 1, 25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2000. 103: 171-179.
19. Spach, K. M., Nashold, F. E., Dittel, B. N. and Hayes, C. E., IL-10 signaling is essential for 1, 25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 6030-6037.
20. Spach, K. M., Pedersen, L. B., Nashold, F. E., Kayo, T., Yandell, B. S., Prolla, T. A. and Hayes, C. E., Gene expression analysis suggests that 1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol. Genomics 2004. 18: 141-151.
21. Pedersen, L. B., Nashold, F. E., Spach, K. M. and Hayes, C. E., 1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J. Neurosci. Res. 2007. 85: 2480-2490.
22. Hayes, C. E., Nashold, F. E., Spach, K. M. and Pedersen, L. B., The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-grand) 2003. 49: 277-300.
23. Meehan, T. F. and DeLuca, H. F., The vitamin D receptor is necessary for 1alpha, 25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch. Biochem. Biophys. 2002. 408: 200-204.
24. Yoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T. et al., Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997. 16: 391-396.
25. Bula, C. M., Huhtakangas, J., Olivera, C., Bishop, J. E., Norman, A. W. and Henry, H. L., Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 2005. 146: 5581-5586.
26. Kennedy, D. W. and Abkowitz, J. L., Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 1997. 90: 986-993.
27. Lee, P. P., Fitzpatrick, D. R., Beard, C., Jessup, H. K., Lehar, S., Makar, K. W., Perez-Melgosa, M. et al., A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001. 15: 763-774.
28. Mao, X., Fujiwara, Y., Chapdelaine, A., Yang, H. and Orkin, S. H., Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 2001. 97: 324-326.
29. Van Cromphaut, S. J., Dewerchin, M., Hoenderop, J. G., Stockmans, I., Van Herck, E., Kato, S., Bindels, R. J. et al., Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. USA 2001. 98: 13324-13329.
30. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L. et al., Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008. 29: 726-776.
31. Meehan, T. F. and DeLuca, H. F., CD8(+) T cells are not necessary for 1 alpha, 25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. USA 2002. 99: 5557-5560.
32. Chang, S. H., Chung, Y. and Dong, C., Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem. 2010. 285: 38751-38755.
33. Lin, W., Haribhai, D., Relland, L. M., Truong, N., Carlson, M. R., Williams, C. B. and Chatila, T. A., Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007. 8: 359-368.
34. Rochel, N., Wurtz, J. M., Mitschler, A., Klaholz, B. and Moras, D., The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 2000. 5: 173-179.
35. Adorini, L. and Penna, G., Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol. 2009. 70: 345-352.
36. Roers, A., Siewe, L., Strittmatter, E., Deckert, M., Schluter, D., Stenzel, W., Gruber, A. D. et al., T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 2004. 200: 1289-1297.
37. Travis, M. A., Reizis, B., Melton, A. C., Masteller, E., Tang, Q., Proctor, J. M., Wang, Y. et al., Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007. 449: 361-365.
38. Cervantes-Barragan, L., Kalinke, U., Zust, R., Konig, M., Reizis, B., Lopez-Macias, C., Thiel, V. and Ludewig, B., Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 2009. 182: 1099-1106.
39. Penna, G., Amuchastegui, S., Giarratana, N., Daniel, K. C., Vulcano, M., Sozzani, S. and Adorini, L., 1, 25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 2007. 178: 145-153.
40. O'Connor, R. A. and Anderton, S. M., Foxp3+regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 2008. 193: 1-11.
41. Cantorna, M. T., Woodward, W. D., Hayes, C. E. and DeLuca, H. F., 1, 25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J. Immunol. 1998. 160: 5314-5319.
42. Chang, J. H., Cha, H. R., Lee, D. S., Seo, K. Y. and Kweon, M. N., 1, 25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 2010. 5: e12925.
43. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R. et al., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603-616.
44. Haribhai, D., Lin, W., Relland, L. M., Truong, N., Williams, C. B. and Chatila, T. A., Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 2007. 178: 2961-2972.
45. Johnson, L. E. and DeLuca, H. F., Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J. Nutr. 2001. 131: 1787-1791.
46. Becher, B., Durell, B. G., Miga, A. V., Hickey, W. F. and Noelle, R. J., The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 2001. 193: 967-974.
47. Mayne, C. G., Amanna, I. J., Nashold, F. E. and Hayes, C. E., Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur. J. Immunol. 2008. 38: 587-598.